Page last updated: 2024-11-05

trifluperidol and Parkinsonian Disorders

trifluperidol has been researched along with Parkinsonian Disorders in 2 studies

Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DIPIAZZA, P1
GORI, EC1
LEVI-MINZI, S1
O'REILLY, PO1
O'REGAN, JB1
LIOANAG, EM1

Other Studies

2 other studies available for trifluperidol and Parkinsonian Disorders

ArticleYear
[CLINICAL EXPERIMENTATION WITH TRIPERIDOL].
    Rassegna di studi psichiatrici, 1963, Volume: 52

    Topics: Biomedical Research; Electromyography; Extrapyramidal Tracts; Hallucinations; Humans; Mental Disorde

1963
TRIPERIDOL (A PRELIMINARY REPORT).
    Diseases of the nervous system, 1964, Volume: 25

    Topics: Adolescent; Biomedical Research; Geriatrics; Mental Disorders; Parasympatholytics; Parkinsonian Diso

1964